September 10, 2021
Chugai Pharmaceutical’s COVID-19 antibody cocktail Ronapreve (casirivimab + imdevimab) has been administered to an estimated 13,000 patients in Japan at roughly 1,700 facilities as of the end of August, the Japanese health ministry said on September 9. Ronapreve earned special...read more